In August 2025, Reuters reported that Pfizer’s experimental sickle cell drug inclacumab failed to meet its main goal in a late-stage study (no significant difference in vaso-occlusive crisis frequency vs placebo). Reuters
Why this still matters
When a trial fails, it can feel discouraging—but it also tells us:
-
which pathways may be less effective than hoped,
-
what future trials should measure differently,
-
and where patients’ real-world needs still aren’t being met.
What families should take away
-
Research progress isn’t linear.
-
A “no” in one trial doesn’t cancel out other advances (including gene therapy progress).
-
Clinical trials remain essential—and participation should always come with clear informed consent and strong support.
If you’re considering a clinical trial
Ask:
-
What phase is it (1, 2, 3)?
-
What’s the main goal (pain crises, anemia markers, organ protection)?
-
What extra visits/testing are required?
-
What costs are covered?
-
What happens if I want to withdraw?